Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 2387 Download: 59

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 14423 Download: 1,426 Web of Science: 63 Crossref: 64

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(3):216-254. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.216

View: 21467 Download: 156 Crossref: 28

1 |

Viewed By 5360	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5312	MAFLD: How is it different from NAFLD?
Viewed By 5207	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3894	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3852	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search